Physician profile
Christopher K Iorio
NPI 1467456285
$510.43
in general payments reported to CMS, 2019-2025
15 companies · $56.16 in 2025
The $56.16 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.46 · 2022: $125 · 2023: $225 · 2024: $77.85 · 2025: $56.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $321 · Education: $37.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $321.39 |
| Education | $37.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $111.46 | 2019-2024 | Shingrix, Arexvy |
| Novartis Pharmaceuticals Corporation | $63.61 | 2022-2023 | |
| Dexcom, INC. | $51.98 | 2023 | Dexcom G6 Transmitter |
| Abbott Laboratories | $41.20 | 2022-2023 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.70 | 2025 | Jardiance |
| Abbvie INC. | $36.97 | 2022 | |
| Corium, LLC | $24.32 | 2023 | Adlarity |
| Astellas Pharma US INC | $24.25 | 2024 | Veozah |
| Amneal Pharmaceuticals LLC | $21.08 | 2023 | Unithroid |
| Boston Scientific Corporation | $19.84 | 2024 | Watchman Access System |
| Insmed, INC. | $18.46 | 2025 | Arikayce |
| Sanofi-Aventis U.S. LLC | $18.33 | 2022 | |
| Medtronic, INC. | $18.10 | 2024 | Intellis Adaptivestim |
| Amgen INC. | $11.88 | 2022 | |
| Pulmonx Corporation | $11.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Iorio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.